Country of the company
Taiwan
Company Address
Tainan CityXinying District
Industrial Category
Medical Goods and Chemical Products Manufacturing
Company Introduction
Company Profile
Syngen Biotech Co., LTD. (Stock Code: 8279) was established on April 28, 1999, and was officially listed on the Taipei Exchange (TPEx) in September 2016.
The company focuses on the research, development, manufacturing, and sales of fermentation-based active pharmaceutical ingredients (APIs) and nutritional health products. It also engages in the agency, leasing, and sales of preventive medicine products and related equipment. Its core technologies include microbial strain identification, preservation, activation and improvement techniques, functional strain screening, microbial fermentation process development, metabolite recovery and purification, and the development of specialized dosage forms for functional health products. Syngen provides one-stop R&D and manufacturing services, covering everything from raw material innovation to production.
Syngen Biotech was among the first to obtain TFDA GMP certification for health supplements. It also holds multiple patents and certifications across Taiwan, Japan, and the United States, including US FDA, NSF GMP, and PMDA overseas AFM registration. Its products, such as probiotic supplements for youth and antiviral probiotics, have received numerous international invention awards. In 2023, the company achieved multiple honors, including its Chairman receiving the Lifetime Achievement Award at the International Outstanding Inventor Awards.
In recent years, Syngen has actively addressed global challenges by integrating ESG (Environmental, Social, and Governance) principles into its corporate culture. The company has completed ISO 14064 greenhouse gas inventory verification and obtained the Dun & Bradstreet ESG Registered Mark, demonstrating its commitment to environmental sustainability.
Syngen’s mission is to advance the health industry through scientific research and technological innovation, enhance people’s quality of life, and provide high-quality health products and professional services to global customers.
Business Philosophy
Guided by the principles of integrity, excellence, innovation, and benefiting society, Syngen has achieved numerous recognitions through the dedicated efforts of its team. These include cGMP certification for APIs, ISO 9001, ISO 22000, HACCP certifications, completion of National Science and Technology Council research projects, the National Biotechnology Quality Award, and the Gold Award for Pharmaceutical Technology R&D from the Ministry of Economic Affairs.
The company will continue to invest in new product research and development projects and is seeking outstanding talents to join us in building a team based on co-creation, co-operation, shared growth, and shared success, creating new opportunities for Taiwan’s biotechnology industry.
Main Service
The company’s main products include active pharmaceutical ingredients (APIs), health and nutritional supplements, and functional ingredients, with a focus on professional research, development, and manufacturing.